Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000061

Options or other derivatives

  • Chief Scientific Officer acquired 4,276.45 shares (option exercise)
  • Chief Scientific Officer acquired 142,547 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jewell Christopher M · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-04-08 Exercise or conversion : show line 1 in the form Stock Option (Right to Buy) −4,276.45 0 D
2024-04-08 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) +142,547 142,547 D
Loading xslF345X05/wk-form4_1712799327.xml…